Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer: a Cochrane Review.
Sathianathen NJ., Philippou YA., Kuntz GM., Konety BR., Gupta S., Lamb AD., Dahm P.
To provide a precis of the Cochrane Collaboration Review of taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer by Sathianathen NJ, Philippou YA, Kuntz GM et al. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD012816. https://doi.org/10.1002/14651858.cd012816.pub2.